{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T21:03:18Z","timestamp":1780002198522,"version":"3.53.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajg.2026.01.007","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T04:06:25Z","timestamp":1773547585000},"page":"192-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical efficacy of Jiawei Yinchenhao decoction combined with ursodeoxycholic acid and probiotics in the management of nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Dong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2876-846X","authenticated-orcid":false,"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2026.01.007_b0005","doi-asserted-by":"crossref","unstructured":"Guo X, Yin X, Liu Z, Wang J. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci. 2022;23(24) 10.3390\/ijms232415489.","DOI":"10.3390\/ijms232415489"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.007_b0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2026.01.007_b0015","doi-asserted-by":"crossref","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, Kassir R, Singhal R, Mahawar K, Ramnarain D. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocrine Disorders. 2022;22(1):6doi:10.1186\/s12902-022-00980-1.","DOI":"10.1186\/s12902-022-00980-1"},{"key":"10.1016\/j.ajg.2026.01.007_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.ajg.2026.01.007_b0025","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ajg.2026.01.007_b0030","doi-asserted-by":"crossref","unstructured":"Roeb E, Geier A. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments. Zeitschrift fur Gastroenterologie. Apr 2019;57(4):508-517. Nichtalkoholische Steatohepatitis (NASH) - aktuelle Behandlungsempfehlungen und zukunftige Entwicklungen. doi:10.1055\/a-0784-8827.","DOI":"10.1055\/a-0784-8827"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.007_b0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.ajg.2026.01.007_b0040","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3748\/wjg.v27.i10.959","article-title":"Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"27","author":"Nadinskaia","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2026.01.007_b0045","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2020.05.128","article-title":"Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK","volume":"529","author":"Wu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajg.2026.01.007_b0050","article-title":"Ursodeoxycholic acid protects against arsenic induced hepatotoxicity by the Nrf2 signaling pathway","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajg.2026.01.007_b0055","doi-asserted-by":"crossref","unstructured":"Mijangos-Trejo A, Nuno-Lambarri N, Barbero-Becerra V, Uribe-Esquivel M, Vidal-Cevallos P, Chavez-Tapia N. Prebiotics and probiotics: therapeutic tools for nonalcoholic fatty liver disease. Int J Mol Sci. 2023;24(19)doi:10.3390\/ijms241914918.","DOI":"10.3390\/ijms241914918"},{"key":"10.1016\/j.ajg.2026.01.007_b0060","doi-asserted-by":"crossref","unstructured":"Carpi RZ, Barbalho SM, Sloan KP, Laurindo LF, Gonzaga HF, Grippa PC, Zutin TLM, Girio RJS, Repetti CSF, Detregiachi CRP, et al. The effects of probiotics, prebiotics and synbiotics in non-alcoholic fat liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review. Int J Mol Sci. 2022;23(15)doi:10.3390\/ijms23158805.","DOI":"10.3390\/ijms23158805"},{"key":"10.1016\/j.ajg.2026.01.007_b0065","doi-asserted-by":"crossref","unstructured":"Xu X, Liu J, Li X, Feng Q, Su Y. Integrated network pharmacology and metabolomics to study the potential mechanism of Jiawei Yinchenhao decoction in chronic hepatitis B. Heliyon. Aug 30 2024;10(16):e36267. doi:10.1016\/j.heliyon.2024.e36267.","DOI":"10.1016\/j.heliyon.2024.e36267"},{"issue":"7","key":"10.1016\/j.ajg.2026.01.007_b0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12272-021-01342-6","article-title":"Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokinetics","volume":"44","author":"Deng","year":"2021","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.ajg.2026.01.007_b0075","doi-asserted-by":"crossref","unstructured":"Song S, Zheng J, Zhao D, Zheng A, Zhu Y, Xu Q, Liu T. Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue. Clin Proteomics. Dec 1 2023;20(1):55. doi:10.1186\/s12014-023-09442-9.","DOI":"10.1186\/s12014-023-09442-9"},{"key":"10.1016\/j.ajg.2026.01.007_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1147067","article-title":"Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice","volume":"14","author":"Yao","year":"2023","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.ajg.2026.01.007_b0085","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3748\/wjg.v23.i7.1125","article-title":"Therapeutic mechanism of Yin-Chen-Hao decoction in hepatic diseases","volume":"23","author":"Li","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"41","key":"10.1016\/j.ajg.2026.01.007_b0090","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.3748\/wjg.v25.i41.6205","article-title":"Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway","volume":"25","author":"Wu","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajg.2026.01.007_b0095","doi-asserted-by":"crossref","unstructured":"Song G, Zou B, Zhao J, Weng F, Li Y, Xu X, Zhang S, Yan D, Jin J, Sun X, et al. Yinchen decoction protects against cholic acid diet-induced cholestatic liver injury in mice through liver and ileal FXR signaling. J Ethnopharmacol. Sep 15 2023;313:116560. doi:10.1016\/j.jep.2023.116560.","DOI":"10.1016\/j.jep.2023.116560"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.007_b0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2026.01.007_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101274","article-title":"NAFLD - a rising metabolic disease","volume":"50","author":"Zeigerer","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.ajg.2026.01.007_b0110","doi-asserted-by":"crossref","unstructured":"Yang R, Jiang D, Xu H, Yang H, Feng L, Wu Q, Xing Y. Network pharmacology and molecular docking integrated with molecular dynamics simulations investigate the pharmacological mechanism of yinchenhao decoction in the treatment of non-alcoholic fatty liver disease. Current computer-aided drug design. Jul 11 2024;doi:10.2174\/0115734099305489240702075128.","DOI":"10.2174\/0115734099305489240702075128"},{"issue":"12","key":"10.1016\/j.ajg.2026.01.007_b0115","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/17474124.2022.2016391","article-title":"Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"15","author":"Yang","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajg.2026.01.007_b0120","doi-asserted-by":"crossref","unstructured":"Li W, Zhu J, Zhou T, Jin Z. Exploring the mechanisms of Yinchenhao decoction against ANIT-induced cholestatic liver injury by lipidomics, metabolomics and network pharmacology. J Pharmac Biomed Anal. 2025;258:116736. doi:10.1016\/j.jpba.2025.116736.","DOI":"10.1016\/j.jpba.2025.116736"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.007_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"issue":"7","key":"10.1016\/j.ajg.2026.01.007_b0130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","article-title":"Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation","volume":"19","author":"Farzanegi","year":"2019","journal-title":"Eur J Sport Sci"},{"issue":"32","key":"10.1016\/j.ajg.2026.01.007_b0135","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.3748\/wjg.v28.i32.4635","article-title":"The mechanism of Yinchenhao decoction in treating obstructive-jaundice-induced liver injury based on Nrf2 signaling pathway","volume":"28","author":"Liu","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.ajg.2026.01.007_b0140","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.007_b0145","doi-asserted-by":"crossref","first-page":"G84","DOI":"10.1152\/ajpgi.00118.2019","article-title":"Role of gut microbiota in liver disease","volume":"318","author":"Albhaisi","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.007_b0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15403\/jgld.2014.1121.271.kby","article-title":"A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial","volume":"27","author":"Kobyliak","year":"2018","journal-title":"J Gastrointestinal Liver Dis: JGLD"},{"key":"10.1016\/j.ajg.2026.01.007_b0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clnesp.2020.06.020","article-title":"The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: a randomized, placebo-controlled, clinical trial","volume":"39","author":"Abhari","year":"2020","journal-title":"Clin Nutrit ESPEN"},{"key":"10.1016\/j.ajg.2026.01.007_b0160","doi-asserted-by":"crossref","unstructured":"Yu B, Lin F, Ning H, Ling B. Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19. Medicine. Aug 13 2021;100(32):e26881. doi:10.1097\/MD.0000000000026881.","DOI":"10.1097\/MD.0000000000026881"},{"issue":"5","key":"10.1016\/j.ajg.2026.01.007_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0323084","article-title":"Quality assessment of medicinal material Daqingye and Banlangen from Isatis tinctoria Fort. reveals widespread substitution with Strobilanthes species","volume":"20","author":"Ngai","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.007_b0170","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2218105","article-title":"Network pharmacology-based approach to research the effect and mechanism of Si-Miao-Yong-an decoction against thromboangiitis obliterans","volume":"55","author":"Zou","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.ajg.2026.01.007_b0175","doi-asserted-by":"crossref","unstructured":"Ye D, Sun J, Li Y. Evaluation of toxicity, bacteriostatic, analgesic, anti-inflammatory, and antipyretic activities of huangqin-honghua-pugongying-jinyinhua extract. Veterinary Sci. 2021;8(12)doi:10.3390\/vetsci8120330.","DOI":"10.3390\/vetsci8120330"},{"key":"10.1016\/j.ajg.2026.01.007_b0180","article-title":"Prediction and quality evaluation of quality markers of Gentiana scabra Bunge. in treatment of liver injury","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ajg.2026.01.007_b0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41598-021-03980-8","article-title":"Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis","volume":"12","author":"Wu","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajg.2026.01.007_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726035","article-title":"Huangbai liniment ameliorates skin inflammation in atopic dermatitis","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajg.2026.01.007_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1385159","article-title":"Supplementation of Crataegi fructus alleviates functional dyspepsia and restores gut microbiota in mice","volume":"11","author":"Hao","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.ajg.2026.01.007_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120284","article-title":"Mechanistic insights into Shanzha Heye Jueming Yin (SZHYJMY) for MASLD: a network pharmacology and experimental study","volume":"353","author":"Miao","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ajg.2026.01.007_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2025.1644192","article-title":"Research progress on the chemical composition of galli gigeriae endothelium corneum","volume":"13","author":"Gan","year":"2025","journal-title":"Front Chem"},{"key":"10.1016\/j.ajg.2026.01.007_b0210","doi-asserted-by":"crossref","unstructured":"Li S, Zheng M, Zhang Z, Peng H, Dai W, Liu J. Galli gigeriae endothelium corneum: its intestinal barrier protective activity in vitro and chemical composition. Chinese medicine. Feb 16 2021;16(1):22. doi:10.1186\/s13020-021-00432-3.","DOI":"10.1186\/s13020-021-00432-3"},{"issue":"Pt 2","key":"10.1016\/j.ajg.2026.01.007_b0215","article-title":"Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2\/STAT3 signaling and NLRP3 inflammasome activation in mice","volume":"319","author":"Lu","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ajg.2026.01.007_b0220","doi-asserted-by":"crossref","unstructured":"Yan J, Zhou Y, Yang Q, Wu J, He X. Evaluation of the safety and efficacy of a Fuling-Zexie decoction for people with asymptomatic hyperuricemia: protocol for a prospective, double-blinded, randomized, placebo-controlled clinical trial. Trials. 2022;23(1):517. doi:10.1186\/s13063-022-06479-3.","DOI":"10.1186\/s13063-022-06479-3"},{"key":"10.1016\/j.ajg.2026.01.007_b0225","doi-asserted-by":"crossref","unstructured":"Ren S, Gao Y, Wang J, Feng J, Li J, Xiang T, Xuan R, Zhou Y. Yinchenhao decoction and its active compound rhein ameliorate intrahepatic cholestasis of pregnancy in mice via modulation of intestinal flora. Phytomedicine : Int J Phytotherapy Phytopharmacol. 2025;148:157397. doi:10.1016\/j.phymed.2025.157397.","DOI":"10.1016\/j.phymed.2025.157397"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:18:46Z","timestamp":1779999526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197926000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1687197926000079"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.01.007","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy of Jiawei Yinchenhao decoction combined with ursodeoxycholic acid and probiotics in the management of nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}